Page 535 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 535

References     3


                   58. Wells PS, Anderson DR, Ginsberg J. Assessment of deep vein     pulmonary embolism severity index in hemodynamically stable
                      thrombosis or pulmonary embolism  by the combined use of   patients with acute pulmonary embolism/clinical perspective.
                      clinical model and noninvasive diagnostic tests. Semin Thromb   Circulation. December 13, 2011;124(24):2716-2724.
                      Hemost. 2000;26(6):643-656.                          75. ten Wolde M, Tulevski II, Mulder JW, et al. Brain natriuretic
                   59. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR.   peptide as a predictor of adverse outcome in patients with
                      Low levels of protein C are associated with poor outcome in   pulmonary embolism.  Circulation. April 29, 2003;107(16):
                      severe sepsis. Chest. September 2001;120(3):915-922.   2082-2084.
                   60. Brathwaite CE, O’Malley KF, Ross SE, Pappas P, Alexander J,     76. Sohne M, Ten Wolde M, Boomsma F, Reitsma JB, Douketis
                      Spence  RK. Continuous  pulse oximetry and the  diagnosis of   JD, Buller HR. Brain natriuretic peptide in hemodynamically
                      pulmonary embolism in critically ill trauma patients. J Trauma.   stable acute pulmonary embolism.  J Thrombosis Haemostasis.
                      October 1992;33(4):528-530; discussion 521-530.        2006;4(3):552-556.
                   61. Stein PD, Athanasoulis C, Alavi A, et al. Complications and     77. Riera-Mestre A, JimÉNez D, Muriel A, et al. Thrombolytic ther-
                      validity of pulmonary angiography in acute pulmonary embo-  apy and outcome of patients with an acute symptomatic pulmo-
                      lism. Circulation. February 1992;85(2):462-468.        nary embolism. J Thrombosis Haemostasis. 2012;10(5):751-759.
                   62. Henry JW, Relyea B, Stein PD. Continuing risk of thromboem-    78. Schellong  SM, Schwarz T,  Kropp  J,  Prescher Y,  Beuthien-
                      boli among patients with normal pulmonary angiograms. Chest.   Baumann B, Daniel WG. Bed rest in deep vein thrombosis and
                      May 1995;107(5):1375-1378.                             the  incidence  of  scintigraphic  pulmonary  embolism.  Thromb
                   63. Forauer AR, McLean GK, Wallace LP. Clinical follow-up of   Haemost. September 1999;82(suppl 1):127-129.
                      patients after a negative digital subtraction pulmonary arterio-    79. Aschwanden M, Labs KH, Engel H, et al. Acute deep vein
                      gram in the evaluation of pulmonary embolism. J Vasc Interv   thrombosis: early mobilization does not increase the frequency
                      Radiol. November-December 1998;9(6):903-908.           of pulmonary embolism. Thromb Haemost. January 2001;85(1):
                                                                             42-46.
                   64. van Rooij WJ, den Heeten GJ, Sluzewski M. Pulmonary embo-
                      lism: diagnosis in 211 patients with use of selective pulmonary     80. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy
                      digital subtraction angiography with a flow-directed catheter.   for venous thromboembolic disease.  Chest. January 2001;119
                      Radiology. June 1995;195(3):793-797.                   (suppl 1):176S-193S.
                                                                           81. Bauer KA. Selective inhibition of coagulation factors: advances
                   65. Fred HL, Axelrad MA, Lewis JM, Alexander JK. Rapid resolu-
                      tion of pulmonary thromboemboli in man. An angiographic   in antithrombotic therapy.  Semin Thromb Hemost. June
                      study. JAMA. June 27, 1966;196(13):1137-1139.          2002;28(suppl 2):15-24.
                   66. Wittram C, Waltman AC, Shepard JA, Halpern E, Goodman LR.      82. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment
                      Discordance between CT and angiography in the PIOPED II   of  pulmonary  embolism.  A  controlled  trial.  Lancet.  June  18,
                      study. Radiology. September 2007;244(3):883-889.       1960;1(7138):1309-1312.
                   67. Mills SR, Jackson DC, Older RA, Heaston DK, Moore AV.     83. Hommes DW, Bura A, Mazzolai L, Buller HR, ten Cate JW.
                                                                             Subcutaneous heparin compared with continuous intravenous
                      The incidence, etiologies, and avoidance of complications of   heparin  administration  in  the  initial  treatment  of  deep  vein
                      pulmonary angiography in a large series.  Radiology. August   thrombosis. A meta-analysis.  Ann Intern Med. February 15,
                      1980;136(2):295-299.                                   1992;116(4):279-284.
                   68. Perlmutt LM, Braun SD, Newman GE, Oke EJ, Dunnick NR.     84. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA.
                      Pulmonary arteriography in the high-risk patient.  Radiology.   Relation between the time to achieve the lower limit of the
                      Jane 1987;162(1 pt 1):187-189.                         APTT therapeutic range and recurrent venous thromboembo-
                   69. Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF.   lism during heparin treatment for deep vein thrombosis. Arch
                      Predicting  adverse  outcome  in  patients  with  acute  pulmonary   Intern Med. December 8-22, 1997;157(22):2562-2568.
                      embolism: a risk score.  Thromb Haemost. October 2000;84(4):     85. Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE,
                      548-552.                                               Morgenthaler TI. Early Anticoagulation Is Associated With
                   70. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pul-  Reduced Mortality for Acute Pulmonary Embolism. Chest. June
                      monary embolism severity index for prognostication in patients   1, 2010;137(6):1382-1390.
                      with acute symptomatic pulmonary embolism. Arch Intern Med.     86. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S.
                      August 9, 2010;170(15):1383-1389.                      The weight-based heparin dosing nomogram compared with a
                   71. Aujesky D, Roy P-M, LeManach CdP, et al. Validation of a   “standard care” nomogram. A randomized controlled trial. Ann
                      model to predict adverse outcomes in patients with pulmonary   Intern Med. November 1, 1993;119(9):874-881.
                      embolism. Eur Heart J. February 2006;27(4):476-481.    87. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as
                   72. Konstantinides S, Geibel A, Olschewski M, et al. Importance   compared with 10 days in the initial treatment of proximal venous
                      of cardiac troponins I and T in risk stratification of patients   thrombosis. N Engl J Med. May 3, 1990;322(18):1260-1264.
                      with acute pulmonary embolism.  Circulation. September 3,     88. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled
                      2002;106(10):1263-1268.                                analyses of randomized trials of streptokinase and heparin in
                   73. Spirk D, Aujesky D, Husmann M, et al. Cardiac troponin test-  phlebographically documented acute deep venous thrombosis.
                      ing and the simplified Pulmonary Embolism Severity Index.   Am J Med. March 1984;76(3):393-397.
                      The SWIss Venous ThromboEmbolism Registry (SWIVTER).     89. Mismetti P, Quenet S, Levine M, et al. Enoxaparin in the treat-
                      Thromb Haemost. November 3, 2011;106(5):978-984.       ment of deep vein thrombosis with or without pulmonary
                   74. Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value   embolism: an individual patient data meta-analysis.  Chest.
                      of the high-sensitivity troponin  T assay and the simplified   October 2005;128(4):2203-2210.








          Section03-O-ref.indd   3                                                                                   1/20/2015   7:10:27 AM
   530   531   532   533   534   535   536   537   538   539   540